-
PIRS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Pieris Pharmaceuticals (PIRS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 19.36 mm | 19.36 mm | 19.36 mm | 19.36 mm | 19.36 mm | 19.36 mm |
Cash burn (monthly) | 122.67 k | 2.13 mm | 1.05 mm | 1.97 mm | (no burn) | 2.44 mm |
Cash used (since last report) | 341.78 k | 5.94 mm | 2.91 mm | 5.48 mm | n/a | 6.79 mm |
Cash remaining | 19.02 mm | 13.42 mm | 16.45 mm | 13.88 mm | n/a | 12.57 mm |
Runway (months of cash) | 155.1 | 6.3 | 15.7 | 7.1 | n/a | 5.2 |
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Dec 24 | George M Jenkins | Common Stock | Buy | Acquire P | No | No | 12.93 | 4,000 | 51.72 k | 180,671 |